HUP0104715A2 - Véredény szerek mágneses magrezonancia diagnosztikához - Google Patents
Véredény szerek mágneses magrezonancia diagnosztikáhozInfo
- Publication number
- HUP0104715A2 HUP0104715A2 HU0104715A HUP0104715A HUP0104715A2 HU P0104715 A2 HUP0104715 A2 HU P0104715A2 HU 0104715 A HU0104715 A HU 0104715A HU P0104715 A HUP0104715 A HU P0104715A HU P0104715 A2 HUP0104715 A2 HU P0104715A2
- Authority
- HU
- Hungary
- Prior art keywords
- acid
- formula
- magnetic resonance
- nuclear magnetic
- calcium
- Prior art date
Links
- 238000005481 NMR spectroscopy Methods 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- -1 Mn(2+) ions Chemical class 0.000 abstract 3
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004380 Cholic acid Substances 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 abstract 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 abstract 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 abstract 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract 1
- 229960002471 cholic acid Drugs 0.000 abstract 1
- 235000019416 cholic acid Nutrition 0.000 abstract 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 abstract 1
- 229960003964 deoxycholic acid Drugs 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical class C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 230000005298 paramagnetic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 abstract 1
- 229960001661 ursodiol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
- Y10S977/928—X-ray agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
- Y10S977/929—Ultrasound contrast agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
- Y10S977/93—MRI contrast agent
Abstract
A tal lm ny t rgya az (I) ltal nos képletű vegyületek param gneses 2-3vegyértékű féminokkal, ezen belül Fe(2+), Fe(Cu(2+), Cr(3+), Gd(3+),Eu(3+), Dy(3+), Yb(3+) vagy Mn(2+) ionokkal képzett komplexeinek, tovbb azok fiziológiailag kompatibilis szerves b zisokkal, ezen belülprimer, szekunder, tercier aminokkal vagy b zikus aminosavakkal vagyolyan szervetlen b zisokkal képzett sóinak, amelyek kationja n trium,k lium, magnézium, kalcium vagy azok elegyei alkalmaz sa az emberi ésllati test vérkeringési rendszerének m gneses magrezonanciasegítségével t"rténő kép megjelenítésére alkalmas diagnosztikumkészítmények elő llít s ra. Az (I) ltal nos képletben X jelentésepoliamino-polikarbonsav ligandum és annak sz rmazékai, ezen belülEDTA, DTPA, DOTA, DOsA, BOPTA; Y epesav-sz rmazék, ezen belülkolinsav-, kenodezoxi-kolinsav-, dezoxi-kolinsav-, urzodezoxi-kolinsav- vagy lito-kolinsav-sz rmazék mind az eredeti form j ban,mind reaktív csoportként hidroxilcsoportot tartalmazó pozíciókbanfunkciós csoporttal ell tva; L b rmely pozícióban X-hez és a 3., 7. és12. pozíciókban Y-hoz kapcsolódó l nc. A tal lm ny t rgy t képezik tovbb az (I) ltal nos képletű, új vegyületek és az ezeket tartalmazódiagnosztikum készítmények. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002802A IT1304501B1 (it) | 1998-12-23 | 1998-12-23 | Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza |
PCT/EP1999/010002 WO2000038738A1 (en) | 1998-12-23 | 1999-12-16 | Blood pool agents for nuclear magnetic resonance diagnostics |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0104715A2 true HUP0104715A2 (hu) | 2002-04-29 |
HUP0104715A3 HUP0104715A3 (en) | 2005-11-28 |
HU228048B1 HU228048B1 (en) | 2012-09-28 |
Family
ID=11381326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104715A HU228048B1 (en) | 1998-12-23 | 1999-12-16 | Blood pool agents for nuclear magnetic resonance diagnostics |
Country Status (20)
Country | Link |
---|---|
US (1) | US6461588B1 (hu) |
EP (2) | EP1140209B1 (hu) |
JP (1) | JP4733271B2 (hu) |
KR (1) | KR100736298B1 (hu) |
CN (2) | CN1263515C (hu) |
AT (1) | ATE405296T1 (hu) |
AU (1) | AU773876B2 (hu) |
CA (1) | CA2355888C (hu) |
CZ (1) | CZ302195B6 (hu) |
DE (1) | DE69939398D1 (hu) |
HK (1) | HK1042432B (hu) |
HU (1) | HU228048B1 (hu) |
IL (2) | IL143730A0 (hu) |
IT (1) | IT1304501B1 (hu) |
MX (1) | MXPA01006344A (hu) |
NO (1) | NO322551B1 (hu) |
PL (1) | PL196474B1 (hu) |
RU (2) | RU2250765C2 (hu) |
WO (1) | WO2000038738A1 (hu) |
ZA (1) | ZA200104820B (hu) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW319763B (hu) * | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
NZ503402A (en) | 1997-10-02 | 2002-03-01 | Epix Medical Inc | Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
IT1317862B1 (it) * | 2000-02-29 | 2003-07-15 | Bracco Spa | Coniugati di acidi biliari con chelati complessi di ioni metallici eloro uso. |
IT1318485B1 (it) * | 2000-04-21 | 2003-08-25 | Bracco Spa | Uso di derivati di acidi biliari coniugati con complessi di ionimetallici nella visualizzazione diagnostica di sistemi microvascolari |
AU2002230398A1 (en) * | 2000-10-06 | 2002-04-29 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
EP1229041A1 (en) * | 2001-02-05 | 2002-08-07 | Bracco Imaging S.p.A. | A process for the preparation of 3-Glutamido bile ester derivatives using N-tBoc methyl pyroglutamate |
US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
EP1302465A1 (en) | 2001-10-11 | 2003-04-16 | BRACCO IMAGING S.p.A. | Enhanced substrate imaging by reversible binding to a paramagnetic complex |
US8420050B2 (en) * | 2003-01-13 | 2013-04-16 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7850947B2 (en) | 2003-01-13 | 2010-12-14 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7611692B2 (en) * | 2003-01-13 | 2009-11-03 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
ATE435035T1 (de) * | 2003-01-13 | 2009-07-15 | Bracco Imaging Spa | Verbesserte linker für radiopharmazeutische verbindungen |
US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
US7922998B2 (en) | 2003-01-13 | 2011-04-12 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
RU2006126637A (ru) * | 2003-12-24 | 2008-01-27 | Бракко Имэджинг С.П.А. (It) | Улучшенные производные пептида, высвобождающего гастрит |
US8529872B2 (en) | 2007-07-11 | 2013-09-10 | Board Of Regents, The University Of Texas System | Seeds and markers for use in imaging |
CN101845112B (zh) * | 2010-06-02 | 2011-09-14 | 华东理工大学 | 一种基于高分子纳米粒子的高灵敏性核磁共振成像造影剂的制备方法 |
EP2665493B1 (en) | 2011-01-20 | 2018-03-21 | Board Of Regents, The University Of Texas System | Mri markers, delivery and extraction systems, and methods of manufacture and use thereof |
US9952300B2 (en) | 2012-03-05 | 2018-04-24 | Bracco Imaging S.P.A. | Dynamic contrast enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues |
CN102766188B (zh) * | 2012-07-24 | 2016-01-13 | 上海交通大学 | 胆固醇衍生物、螯合物、重组高密度脂蛋白及其用途 |
GB201421163D0 (en) * | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Formulations of metal complexes |
KR20200004861A (ko) | 2017-05-05 | 2020-01-14 | 퓨전 파마슈티칼즈 인크. | Igf-1r 모노클로날 항체 및 그의 용도 |
EA201992595A1 (ru) | 2017-05-05 | 2020-04-21 | Фьюжн Фармасьютикалс Инк. | Усиление фармакокинетики бифункциональных хелатов и их применения |
US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
JP7463006B2 (ja) * | 2018-05-30 | 2024-04-08 | トランスレイト バイオ, インコーポレイテッド | ステロイド性部分を含むカチオン性脂質 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1213029B (it) * | 1986-01-30 | 1989-12-07 | Bracco Ind Chimica Spa | Chelati di ioni metallici paramagnetici. |
US5227474A (en) * | 1987-02-13 | 1993-07-13 | Abbott Laboratories | Bifunctional chelating agents |
US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
DE3930696A1 (de) * | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
NO940115D0 (no) * | 1994-01-13 | 1994-01-13 | Nycomed Imaging As | Kontrastmidler for roentgen- og magnettomografisk avbildning |
WO1995028967A1 (en) * | 1994-04-20 | 1995-11-02 | Nycomed Salutar Inc | Contrast agents |
IT1269839B (it) * | 1994-05-26 | 1997-04-15 | Bracco Spa | Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi |
JPH11116542A (ja) * | 1997-10-06 | 1999-04-27 | Sogo Pharmaceut Co Ltd | γ−グルタミン酸アミド類の製造法 |
-
1998
- 1998-12-23 IT IT1998MI002802A patent/IT1304501B1/it active
-
1999
- 1999-05-26 US US09/318,618 patent/US6461588B1/en not_active Expired - Lifetime
- 1999-12-16 DE DE69939398T patent/DE69939398D1/de not_active Expired - Lifetime
- 1999-12-16 CN CNB998157929A patent/CN1263515C/zh not_active Expired - Fee Related
- 1999-12-16 EP EP99963556A patent/EP1140209B1/en not_active Expired - Lifetime
- 1999-12-16 EP EP08004643.6A patent/EP1935435B1/en not_active Expired - Lifetime
- 1999-12-16 MX MXPA01006344A patent/MXPA01006344A/es active IP Right Grant
- 1999-12-16 IL IL14373099A patent/IL143730A0/xx active IP Right Grant
- 1999-12-16 JP JP2000590689A patent/JP4733271B2/ja not_active Expired - Fee Related
- 1999-12-16 WO PCT/EP1999/010002 patent/WO2000038738A1/en active IP Right Grant
- 1999-12-16 CA CA002355888A patent/CA2355888C/en not_active Expired - Fee Related
- 1999-12-16 RU RU2001120351/15A patent/RU2250765C2/ru not_active IP Right Cessation
- 1999-12-16 KR KR1020017007945A patent/KR100736298B1/ko not_active IP Right Cessation
- 1999-12-16 PL PL349488A patent/PL196474B1/pl unknown
- 1999-12-16 CN CNB2006100676912A patent/CN100450996C/zh not_active Expired - Fee Related
- 1999-12-16 HU HU0104715A patent/HU228048B1/hu not_active IP Right Cessation
- 1999-12-16 AU AU19807/00A patent/AU773876B2/en not_active Ceased
- 1999-12-16 AT AT99963556T patent/ATE405296T1/de not_active IP Right Cessation
- 1999-12-16 RU RU2004127136/04A patent/RU2395490C2/ru not_active IP Right Cessation
- 1999-12-16 CZ CZ20012330A patent/CZ302195B6/cs not_active IP Right Cessation
-
2001
- 2001-06-13 IL IL143730A patent/IL143730A/en not_active IP Right Cessation
- 2001-06-13 ZA ZA200104820A patent/ZA200104820B/en unknown
- 2001-06-22 NO NO20013154A patent/NO322551B1/no not_active IP Right Cessation
-
2002
- 2002-05-04 HK HK02103398.0A patent/HK1042432B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104715A2 (hu) | Véredény szerek mágneses magrezonancia diagnosztikához | |
DE69117973D1 (de) | Molekularsieb enthaltende pharmazeutische ionen für diagnose | |
US5128121A (en) | Mixture of a positive and negative contrast agent for magnetic resonance imaging | |
RU2001120351A (ru) | Агенты для кровяного депо для диагностики с помощью ядерного магнитного резонанса | |
US5141740A (en) | Complexes and compositions for magnetic resonance imaging and usage methods | |
EP0436579B1 (en) | Chelate compositions | |
IL175667A (en) | Imaging factor that includes a synthetic caspase-3 inhibitor marked with the neuroimaging agent, a radiopharmaceutical containing it, a kit for preparation of the preparation and a method for diagnosis based on it | |
IL129173A0 (en) | Gas-filled microvesicles and a process for preparing an mri contrast agent containing same | |
ES8603757A1 (es) | Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn | |
NO873237L (no) | Fremgangsmaate ved nmr-avbilding. | |
ZA965101B (en) | Blood-pool imaging compositions use and method | |
JP2003525306A5 (hu) | ||
DE69425572T2 (de) | Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel | |
JP2002533420A5 (hu) | ||
WO1994001393A1 (en) | Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound | |
US20160051706A1 (en) | Process for producing a complex of a lanthanide with a macrocyclic ligand | |
KR970704713A (ko) | 대환식 킬레이트제, 이들의 킬레이트 및 진단 분야에서의 이의 용도(Macrocyclic Chelants, Their Chelates and Uses Thereof in the Diagnostic Field) | |
IL108433A0 (en) | Dtpa metal complex derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof | |
US5314680A (en) | Polyazamacrocycles for magnetic resonance imaging | |
US5368839A (en) | Insoluble salts of lanthanides for the visual display using nuclear magnetic resonance, of the gastro-intestinal tract | |
US6559330B1 (en) | Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents | |
EP1210353B1 (en) | Calcium complex of phosphorus containing ethylenediamine derivatives | |
ES2942312T3 (es) | Método de hidrólisis de éster terc-butílico usado en agente de contraste de gadolinio | |
US20030203879A1 (en) | Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents | |
IT1271043B (it) | Chelati paramagnetici per diagnosi in risonanza magnetica nucleare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |